In-vitro Toxicology Testing Market Is Expected To Reach USD 44.7 Billion By 2022, Growing At An Estimated CAGR Of 10.5% From 2015 To 2022: Grand View Research, Inc.

In-vitro Toxicology Testing Market Worth
$44.7 Billion By 2022
The global in-vitro toxicology testing market is expected to reach USD 44.7 billion by 2022
growing at an estimated CAGR of 10.5% from 2015 to 2022, according to a new report by Grand
View Research, Inc. This expected rise in demand can be ascribed to novel and promising
technologies in analytical laboratories.
Advancement in bioinformatics based research for development of efficient software algorithms
in order to carry out efficient stimulation of in-silico animal models in determination of
toxicological response is expected to influence sector growth through to 2022.
Furthermore, rapid up gradation of databases that serve information for toxicity profiling and
lethal dose determination of different compounds is anticipated to create significant potential for
growth in this market during the forecast period.
Rise in government imposed restrictions and guidelines on usage of animals for pre-clinical
research and toxicology testing is also attributive towards estimated progress in this industry.
Additionally, increasing R&D in biotechnology sector for enhancement in cell based assays and
cell culture techniques, is anticipated to impart significant growth potential in this sector.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/in-
vitro-toxicology-testing-market

North America In-vitro Toxicology Testing Market, By Technology 2012-2022 (USD
Million)
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. In-Vitro Toxicology Testing Industry Outlook
3.1. Market Segmentation
3.2. Market Size and Growth Prospects
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. In-Vitro Toxicology Testing Market Dynamics
3.4. Key Opportunities Prioritized
3.5. Industry Analysis -Porter’s
3.6. In-Vitro Toxicology Testing Market PESTEL Analysis
Chapter 4. In-Vitro Toxicology Testing Outlook, by End-use
4.1. Pharmaceutical Industry
4.1.1. Pharmaceutical Industry Market Estimates and Forecasts, 2012 - 2022
(USD Million)
4.2. Cosmetics & Household Products

4.2.1. Cosmetics & Household Products Market Estimates and Forecasts, 2012 -
2022 (USD Million)
4.3. Diagnostics
4.3.1. Diagnostics Market Estimates and Forecasts, 2012 - 2022(USD Million)
4.4. Chemicals Industry
4.4.1. Chemicals Industry Market Estimates and Forecasts, 2012 - 2022 (USD
Million)
4.5. Food Industry
4.5.1. Food Industry Market Estimates and Forecasts, 2012 - 2022 (USD Million)
Chapter 5. In-Vitro Toxicology Testing by Technology Outlook
5.1. Cell Culture Technology
5.1.1. Cell Culture Technology Market Estimates and Forecasts, 2012 - 2022
(USD Million)
5.2. High Throughput Technology
5.2.1. High Throughput Technology Market Estimates and Forecasts, 2012 -
2022 (USD Million)
5.3. Molecular Imaging
5.3.1. Molecular Imaging Market Estimates and Forecasts, 2012 - 2022 (USD
Million)
5.4. OMICS Technology
5.4.1. OMICS Technology Industry Market Estimates and Forecasts, 2012 - 2022
(USD Million)
Chapter 6. In-Vitro Toxicology Testing Outlook, by Application
6.1. Systemic Toxicology
6.1.1. Systemic Toxicology Industry Market Estimates and Forecasts, 2012 -
2022 (USD Million)
6.2. Dermal Toxicity
6.2.1. Dermal Toxicity Market Estimates and Forecasts, 2012 - 2022 (USD
Million)
6.3. Endocrine Disruption
6.3.1. Endocrine Disruption Market Estimates and Forecasts, 2012 - 2022(USD
Million)
6.4. Occular Toxicity
6.4.1. Occular Toxicity Industry Market Estimates and Forecasts, 2012 - 2022
(USD Million)
Chapter 7. In-Vitro Toxicology Testing Outlook, by Method
7.1. Cellular Assay
7.1.1. Cellular Assay Industry Market Estimates and Forecasts, 2012 - 2022
(USD Million)

7.2. Biochemical Assay
7.2.1. Biochemical Assay Market Estimates and Forecasts, 2012 - 2022 (USD
Million)
7.3. In-Silico
7.3.1. In-silico Market Estimates and Forecasts, 2012 - 2022(USD Million)
7.4. Ex-vivo
7.4.1. Ex-vivo Industry Market Estimates and Forecasts, 2012 - 2022 (USD
Million)
Chapter 8. In-vitro toxicology testing Regional Outlook
8.1. North America
8.1.1. North America In-Vitro Toxicology Testing Market, 2012 - 2022 (USD
Million)
8.2. Europe
8.2.1. Europe In-vitro Toxicology Testing Market, 2012 - 2022 (USD Million)
8.3. Asia Pacific
8.3.1. Asia Pacific In-vitro Toxicology Testing Market, 2012 - 2022 (USD
Million)
8.4. RoW
8.4.1. RoW In-vitro Toxicology Testing Market, 2012 - 2022 (USD Million)
Chapter 9. Competitive Landscape
9.1. Agilent Technologies
9.1.1. Company Overview
9.1.2. Revenue Analysis
9.1.3. Product Benchmarking
9.1.4. Strategic Development
9.2. Alere, Inc
9.3. Bio-Rad Laboratories
9.4. Sigma Aldrich Corporation LLC.

9.5. Charles River Laboratories, Inc.
9.6. Thermo Fisher Scientific Inc.
9.7. Catalent, Inc.
9.8. Eurofins Scientific, Inc
9.9. GE Healthcare
9.10. Quest Diagnostics
9.11. Covance Inc.
9.12. Cyprotex

Browse full report @ http://www.grandviewresearch.com/industry-analysis/in-vitro-
toxicology-testing-market
List of Tables
1. In-vitro toxicology testing market- Industry Snapshot & Key Buying Criteria, 2012 - 2022
2. Global in-vitro toxicology testing market, by end-use, 2012 - 2022 (USD Million)
3. Global in-vitro toxicology testing market, by technology, 2012 - 2022 (USD Million)
4. Global in-vitro toxicology testing market, by application, 2012 - 2022 (USD Million)
5. Global in-vitro toxicology testing market, by method, 2012 - 2022 (USD Million)
6. Global in-vitro toxicology testing market, by region, 2012 - 2022 (USD Million)
7. In-vitro toxicology testing- Key market driver analysis
8. In-vitro toxicology testing - Key market restraint analysis
9. North America in-vitro toxicology testing market, by end-use, 2012 - 2022 (USD Million)
10. North America in-vitro toxicology testing market, by technology, 2012 - 2022 (USD Million)
11. North America in-vitro toxicology testing market, by application, 2012 - 2022 (USD Million)
12. North America in-vitro toxicology testing market, by method, 2012 - 2022 (USD Million)
13. Europe in-vitro toxicology testing market, by end-use, 2012 - 2022 (USD Million)
14. Europe in-vitro toxicology testing market, by technology, 2012 - 2022 (USD Million)
15. Europe in-vitro toxicology testing market, by application, 2012 - 2022 (USD Million)
16. Europe in-vitro toxicology testing market, by method, 2012 - 2022 (USD Million)
17. Asia Pacific in-vitro toxicology testing market, by end-use, 2012 - 2022 (USD Million)
18. Asia Pacific in-vitro toxicology testing market, by technology, 2012 - 2022 (USD Million)
19. Asia Pacific in-vitro toxicology testing market, by application, 2012 - 2022 (USD Million)
20. Asia Pacific in-vitro toxicology testing market, by method, 2012 - 2022 (USD Million)
21. RoW in-vitro toxicology testing market, by end-use, 2012 - 2022 (USD Million)
22. RoW in-vitro toxicology testing market, by technology, 2012 - 2022 (USD Million)
23. RoWi n-vitro toxicology testing market, by application, 2012 - 2022 (USD Million)
24. RoW in-vitro toxicology testing market, by method, 2012 - 2022 (USD Million)
For More Information visit http://www.grandviewresearch.com/industry-analysis/in-vitro-
toxicology-testing-market
List of Figures
1. In-vitro toxicology testing market segmentation
2. Global in-vitro toxicology testing market, 2012 - 2022 (USD Million)
3. In-vitro toxicology testing market dynamics

4. Key opportunities prioritized,.2014
5. In-vitro toxicology testing market - Porter’s Analysis
6. In-vitro toxicology testing market - PESTEL analysis
7. In-vitro toxicology testing revenue share, by end-use, 2014& 2022
8. Global pharmaceutical industry market, 2012 - 2022 (USD Million)
9. Global cosmetics & household products market, 2012 - 2022 (USD Million)
10. Global diagnostics market, 2012 - 2022 (USD Million)
11. Global chemical industry market, 2012 - 2022 (USD Million)
12. Global food industry market, 2012 - 2022 (USD Million)
13. In-vitro toxicology testing revenue share, by technology, 2014& 2022
14. Global cell culture technology market, 2012 - 2022 (USD Million)
15. Global high throughput technology market, 2012 - 2022 (USD Million)
16. Global molecular imaging market, 2012 - 2022 (USD Million)
17. Global OMICS technology market, 2012 - 2022 (USD Million)
18. In-vitro toxicology testing revenue share, by application, 2014& 2022
19. Global systemic toxicology market, 2012 - 2022 (USD Million)
20. Global dermal toxicity market, 2012 - 2022 (USD Million)
21. Global endocrine disruption market, 2012 - 2022 (USD Million)
22. Global ocular toxicity market, 2012 - 2022 (USD Million)
23. In-vitro toxicology testing revenue share, by method, 2014& 2022
24. Global cellular assay market, 2012 - 2022 (USD Million)
25. Global biochemical assay market, 2012 - 2022 (USD Million)
26. Global in-silico market, 2012 - 2022 (USD Million)
27. Global ex-vivo market, 2012 - 2022 (USD Million)
28. In-vitro toxicology testing revenue share, by region, 2014& 2022
29. North America in-vitro toxicology testing market, 2012 - 2022 (USD Million)
30. Europe in-vitro toxicology testing market, 2012 - 2022 (USD Million)
31. Asia Pacific in-vitro toxicology testing market, 2012 - 2022 (USD Million)
32. RoW in-vitro toxicology testing market, 2012 - 2022 (USD Million)
Further key findings from the study suggest:
 Pharmaceutical and cosmetic industry together accounted for almost 65% of total revenue
generated in this sector for 2014. This large share can be attributed to rapid novel product
launches for treatment of different diseased conditions wherein toxicological testing is
the pre-requisite step.
 Cell culture technology contributed for over 42% of the revenue generated in the industry
with respect to technology owing to critical role of cell culture in biotechnological
development and cell based analysis

 Omics technology is anticipated to register lucrative growth thereby driving demand due
to advancement in sequencing methods and availability of different platforms depending
on source and target sequence.
 As a fundamental process in biopharmaceutical or pharmaceutical product development
toxicological testing finds application in determination of systemic, dermal, & ocular
toxicity as well as endocrine disruption
 Amongst the above enlisted applications, dermal toxicity is expected to witness
significant progress with a CAGR of approximately 13% due to comparatively higher
incidence of side effects associated with skin after administration of several compounds.
 North America accounted for the largest share of over 45% in revenue in 2014 owing to
presence of significant number of sector players that are implementing advanced in-vitro
technology. Furthermore, presence of stringent regulations pertaining to animal usage in
toxicity analysis attributive towards high demand of in-vitro tests in this region.
 Asia Pacific is expected to witness lucrative CAGR of over 11% from 2015 to 2022 due
to rapid improvement in health care infrastructure in developing economies of this region
which in turn contributes to regional progress in industry.
 Key participants of in-vitro toxicology testing industry are Quest Diagnostics, Covance,
Cyprotex, Alere, Inc, Charles River Laboratories, GE Healthcare, Thermo Fisher
Scientific, Eurofins Scientific, Inc., Agilent Technologies, Catalent Pharma Solutions,
Sigma Aldrich, and Bio-Rad.
 These participants are involved in collaborations with bioinformatics research firms in
order to develop novel in-silico algorithms for computational estimation of toxicity of
pharmaceutical and chemical products.
 Moreover, these market entities are also focusing on entering untapped regions in order to
maintain their share in market revenue.
Request free sample of this Report @ http://www.grandviewresearch.com/industry-
analysis/in-vitro-toxicology-testing-market/request
Grand View Research has segmented in-vitro toxicology testing market on the basis of end use,
technology, method, application, and region:
Global In-vitro Toxicology Testing Outlook, by End-use (Revenue, USD Million, 2012 –
2022)

 Pharmaceutical industry
 Cosmetics & household products
 Diagnostics
 Chemical industry
 Food industry
Global In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2012 –
2022)
 Cell culture technology
 High throughput technology
 Molecular imaging
 OMICS technology
Global In-vitro Toxicology Testing Outlook, by Application (Revenue, USD Million, 2012 –
2022)
 Systemic Toxicology
 Dermal Toxicity
 Endocrine Disruption
 Occular toxicity
Global In-vitro Toxicology Testing Outlook, by Method (Revenue, USD Million, 2012 –
2022)
 Cellular Assay
 Biochemical Assay
 In-Silico
 Ex-vivo
In-vitro Toxicology Testing Regional Outlook (Market Revenue in USD Million, 2012 - 2022
)
 North America
 Europe
 Asia Pacific
 RoW
Browse All Reports of this category @
http://www.grandviewresearch.com/industry/clinical-diagnostics

About Grand View Research
Grand View Research, Inc. is a market research and consulting company that provides off-the-
shelf, customized research reports and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and energy. With a deep-
seated understanding of varied business environments, Grand View Research provides strategic
objective insights.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: Grand View Research
Blog Site: http://www.divog.org/

In-vitro Toxicology Testing Market Is Expected To Reach USD 44.7 Billion By 2022, Growing At An Estimated CAGR Of 10.5% From 2015 To 2022: Grand View Research, Inc.

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Empfohlen

Empfohlen (20)

In-vitro Toxicology Testing Market Is Expected To Reach USD 44.7 Billion By 2022, Growing At An Estimated CAGR Of 10.5% From 2015 To 2022: Grand View Research, Inc.